Chronic Myeloproliferative Disorders Unknown Status Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00589602T-Cell Depletion, Donor HSCT, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other DiseasesTreatment